Advances in Hematological Malignancies
Recent years have witnessed remarkable strides in the area of hematological malignancies. Novel treatment modalities such as targeted therapy, immunotherapies, and gene editing are altering the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering potential for more effective treat